Core Laboratories Inc. (NYSE:CLB – Get Free Report) has been assigned a consensus recommendation of “Reduce” from the four brokerages that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation and two have issued a hold recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $18.75.
CLB has been the topic of several recent analyst reports. Stifel Nicolaus upped their target price on Core Laboratories from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, April 26th. Bank of America dropped their price target on Core Laboratories from $17.00 to $16.00 and set an “underperform” rating on the stock in a research note on Monday, April 15th.
Read Our Latest Stock Analysis on CLB
Institutional Investors Weigh In On Core Laboratories
Core Laboratories Trading Down 1.5 %
Shares of NYSE CLB opened at $19.99 on Thursday. The company has a quick ratio of 1.85, a current ratio of 2.68 and a debt-to-equity ratio of 0.68. Core Laboratories has a twelve month low of $13.82 and a twelve month high of $27.94. The business has a fifty day simple moving average of $17.89 and a two-hundred day simple moving average of $16.88. The firm has a market cap of $937.53 million, a PE ratio of 22.72, a price-to-earnings-growth ratio of 1.28 and a beta of 2.41.
Core Laboratories (NYSE:CLB – Get Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The oil and gas company reported $0.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.02. The business had revenue of $129.64 million for the quarter, compared to the consensus estimate of $124.47 million. Core Laboratories had a return on equity of 15.71% and a net margin of 8.18%. Analysts expect that Core Laboratories will post 0.73 earnings per share for the current fiscal year.
Core Laboratories Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 28th. Shareholders of record on Monday, May 6th were given a $0.01 dividend. The ex-dividend date was Friday, May 3rd. This represents a $0.04 annualized dividend and a yield of 0.20%. Core Laboratories’s dividend payout ratio is presently 4.55%.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Recommended Stories
- Five stocks we like better than Core Laboratories
- Options Trading – Understanding Strike Price
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- What is the Shanghai Stock Exchange Composite Index?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.